Treatment With Immunoglobulin And Adverse Events In PID (Primary Immunodeficiency)

被引：0
|
作者：
Puget, Sophie [1 ]
Darnige, Luc [2 ]
机构：
[1] LFB Biomed, Int Sci Affairs Unit, Lublin, Poland
[2] Hosp Europeen Georges Pompidou, AP HP Paris, Haematol Unit, Paris, France
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2015年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P43
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [1] Treatments with immunoglobulin and adverse events in PID (Primary Immunodeficiencies)
    Luc, Darnige
    Sophie, Puget
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 : S49 - S49
  • [2] Adverse Events (ae) to Intravenous Immunoglobulin (ivig) in Patients with Primary Immunodeficiency (pid) During Regular Replacement Therapy
    Bichuete-Silva, D. C.
    Furlan, F. P.
    Nobre, F. A.
    Pereira, C. T. M.
    Goncalves, T. R. T.
    Gouveia-Pereira, M.
    Rota, R.
    Mazzucchelli, J. L.
    Costa-Carvalho, B. T.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 : S110 - S110
  • [3] Adverse Reactions During Immunoglobulin Infusions in Primary Immunodeficiency Patients
    Branco, A. B. X. C.
    Franco, D. C.
    Bastos, C. P.
    Grinapel, R.
    Barros, J. A. S.
    Felix, M. M.
    Vianna, J. C.
    Soares, M. S.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S57 - S57
  • [4] ADVERSE EVENTS RELATED TO ENDOVENOUS HUMAN IMMUNOGLUBULIN INFUSION FOR THE TREATMENT OF PATIENTS WITH PRIMARY IMMUNODEFICIENCY
    Costa-Carvalho, Beatriz Tavares
    Bichuete-Silva, Danielli Christinni
    Furlan, Fernanda Patini
    Negrini Fagundes, Anna Tereza
    Nobre, Fernanda Aimee
    Machado Pereira, Camila Teles
    Gouveia-Pereira, Mariana
    Tranquilini GonCalves, Tessa Rachel
    Rota, Rafael
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (03) : 701 - 701
  • [5] Intravenous Immunoglobulin in the Treatment of Primary Immunodeficiency Diseases
    De Ranieri, Deirdre
    Fenny, Nana Sarkoah
    PEDIATRIC ANNALS, 2017, 46 (01): : E8 - E12
  • [6] INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN THE PRIMARY IMMUNODEFICIENCY DISEASES
    CUNNINGHAMRUNDLES, C
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1988, 8 (01) : 17 - 28
  • [7] Impact of Endogenous IgG Levels on Immunoglobulin Replacement Efficiency in Primary Immunodeficiency (PID)
    Jolles, Stephen R.
    Ponsford, Mark J.
    Lawo, John-Philip
    Rojavin, Mikhail
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB201 - AB201
  • [8] Intrainfusion and postinfusion adverse events related to intravenous immunoglobulin therapy in immunodeficiency states
    Tcheurekdjian, Haig
    Martin, Jamila
    Kobayashi, Roger
    Wasserman, Richard
    Hostoffer, Robert
    ALLERGY AND ASTHMA PROCEEDINGS, 2006, 27 (06) : 532 - 536
  • [9] Interim Analysis of Infusion Characteristics and Adverse Events During Facilitated Subcutaneous Immunoglobulin Treatment for Primary Immunodeficiency Diseases: Global Post Authorization Safety Study
    Rubinstein, Arye
    Bridges, Tracy
    Wedner, H. James
    McNeil, Donald
    Wasserman, Richard L.
    Tachdjian, Raffi
    Fielhauer, Katharina
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S53 - S54
  • [10] Treatment preference on the new Subcutaneous Immunoglobulin 20% (SCIG 20%) treatment in patients with Primary Immunodeficiency Diseases (PID) in Europe (EU)
    Gladiator, A.
    Meckley, L.
    Berner, T.
    Engl, W.
    Ito, D.
    Yel, L.
    SWISS MEDICAL WEEKLY, 2017, 147 : 57S - 57S
12345